1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Innate Pharma
  6. Consensus
    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
Real-time Euronext Paris  -  05/20 11:35:15 am EDT
2.906 EUR   -1.69%
05/20INNATE PHARMA : Outcome of Innate Pharma's 2022 Annual General Meeting - Form 6-K
PU
05/20Innate Pharma S.A. Announces Supervisory Board Changes
CI
05/10TRANSCRIPT : Innate Pharma S.A., Q1 2022 Earnings Call, May 10, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on INNATE PHARMA
Target Price consensus revisions : last 18 months
Recommendations (Chart) INNATE PHARMA
Analyst Recommendations on INNATE PHARMA
2021ANALYST RECOMMENDATIONS : BHP, Lear, Naked Wines, Teradata, Visteon...
2021INNATE PHARMA S A : SVB Leerink Upgrades Innate Pharma to Outperform from Market Perform
MT
2020INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From Outperform, Adjusts Price Targ..
MT
2020INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50 From $13, Keeps at Buy
MT
2020INNATE PHARMA S A : Goldman Sachs Starts Innate Pharma at Neutral With $4.75 Price Target
MT
2015France's 'economic patriotism' is not what it seems
RE
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 2,91 €
Average target price 8,12 €
Spread / Average Target 179%
High Price Target 12,00 €
Spread / Highest target 313%
Low Price Target 4,00 €
Spread / Lowest Target 37,6%
Consensus detail
Consensus revision (last 18 months)